LOGO
Reply to Thread New Thread
Old 09-05-2011, 08:40 PM   #1
Coollabioto

Join Date
Oct 2005
Posts
483
Senior Member
Default Surveying the present use of fat-derived stem cells
I disagree with the part about less pain than a marrow extraction. The adipose treatment I had was far more difficult than any marrow extraction I have had. This is not always the case however. If you have a skilled surgeon that has a lot of liposuction experience, there should not be that much pain involved. Live and learn.


Fight Aging Newsletter
May 3, 2011

One of the more widespread present uses of stem cells in the clinic
involves cells derived from a patient's own fat tissue. Here an Indian
publication surveys the landscape: "Stem cells offer exciting medical
promise for repairing or replacing organs that are diseased, damaged
or worn out. This promise of repair and regeneration was taken a step
further with the advent of Adipose (Fat) Derived Stem Cells (ADSC)
which are derived from our own excess body fat. Much like recycling
waste, our excess fat can be processed to give us a better quality of
life. Currently used for breast augmentation and reconstruction as
well as plastic surgery, ADSC are being researched for most
debilitating diseases like Myocardial Infarction (MI), diabetes
mellitus and neurodegenerative diseases also. ... Clinically, ADSCs
have the advantage over their bone marrow-derived counterparts,
because of their abundance in numbers - eliminating the need for
culturing over days to obtain a therapeutically viable number - and
the ease of the harvest procedure itself - being less painful than the
harvest of bone marrow. This, in theory, means that an autologous
transplant of ADSC will not only work in much the same way as the
successes shown using marrow-derived mesenchymal stem cell transplant,
but also be of minimal risk to the patient. ... I was a part of
adipose tissue derived stem cell trial in spinal cord injury and
critical limb ischemia. We could not have a large number of subjects
because of cost considerations, but the results were encouraging in
spinal cord injury. However in critical limb ischemia results were
poor as compared to good results of other studies with bone marrow
derived stem cells ... Apart from these cases, Mumbai based Kasiak
Research is using ADSC for idiopathic pulmonary fibrosis. ... Apart
from this, there are a number of trials investigating applications in
ischemic heart disease around the world."
Coollabioto is offline



Reply to Thread New Thread

« Previous Thread | Next Thread »

Currently Active Users Viewing This Thread: 1 (0 members and 1 guests)
 

All times are GMT +1. The time now is 09:33 AM.
Copyright ©2000 - 2012, Jelsoft Enterprises Ltd.
Search Engine Optimization by vBSEO 3.6.0 PL2
Design & Developed by Amodity.com
Copyright© Amodity